Showing results (81-90 of 160) with videos related to
Sort By:
Pageof 16
Oncotargets and Therapy|October 8, 2016
Weekly nanoparticle albumin-bound paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinomaHai-Ying Wang, Zhi-Hua Yao, Hong Tang, et al.Journal of the American Chemical Society|December 9, 2022
Triple-Helical Self-Assembly of Atomically Precise NanoclustersHao Li, Pu Wang, Chen Zhu, et al.Frontiers in Cell and Developmental Biology|May 31, 2021
Validation of a Novel Fgf10 Knock-in Mouse Line Targeting FGF10Pos Cells PostnatallyXuran Chu, Sara Taghizadeh, Ana Ivonne Vazquez-Armendariz, et al.Frontiers in Genetics|December 6, 2021
Corrigendum: FGF10 Protects Against Renal Ischemia/Reperfusion Injury by Regulating Autophagy and Inflammatory SignalingXiaohua Tan, Hongmei Zhu, Qianyu Tao, et al.Frontiers in Genetics|December 12, 2018
FGF10 Protects Against Renal Ischemia/Reperfusion Injury by Regulating Autophagy and Inflammatory SignalingXiaohua Tan, Hongmei Zhu, Qianyu Tao, et al.Aging|January 21, 2020
Fibroblast growth factor 10 alleviates particulate matter-induced lung injury by inhibiting the HMGB1-TLR4 pathwayLingjing Liu, Chenjian Song, Jingli Li, et al.The Journal of Physical Chemistry Letters|May 1, 2023
Dynamic Evolving Exothermicity Steers Ultrafast Formation of a Correlated Triplet Pair StateYishi Wu, Lina Lu, Buyang Yu, et al.Molecular Medicine (Cambridge, Mass.)|June 28, 2022
FGF1 alleviates LPS-induced acute lung injury via suppression of inflammation and oxidative stressQhaweni Dhlamini, Wei Wang, Guifeng Feng, et al.Chemical Science|September 21, 2022
Flavanthrene derivatives as photostable and efficient singlet exciton fission materialsXian Fei, San Zhang, Dong Zhai, et al.Cancer Investigation|February 13, 2009
PDLIM4, an actin binding protein, suppresses prostate cancer cell growthDonkena Krishna Vanaja, Michael E Grossmann, John C Cheville, et al.Pageof 16